Correspondence 0001640334-25-000159 from Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362) (LEXX)
Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362)
Date: Jan. 28, 2025 · CIK: 0001348362 · Accession: 0001640334-25-000159
AI Filing Summary & Sentiment
File numbers found in text: 333-284407
Letter
Re:
lxrp_corresp.htmJanuary 28, 2025
VIA EDGAR AND FACSIMILE
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Lexaria Bioscience Corp. (the “Company”)
Registration Statement on Form S-3
File No. 333-284407
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time on January 30, 2025, or as soon thereafter as is practicable.
If you have any questions, please call Avital Perlman, Esq. at (212) 930-9700.
Very truly yours,
LEXARIA BIOSCIENCE CORP.
Show Raw Text
CORRESP
1
filename1.htm
lxrp_corresp.htmJanuary 28, 2025
VIA EDGAR AND FACSIMILE
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re:
Lexaria Bioscience Corp. (the “Company”)
Registration Statement on Form S-3
File No. 333-284407
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time on January 30, 2025, or as soon thereafter as is practicable.
If you have any questions, please call Avital Perlman, Esq. at (212) 930-9700.
Very truly yours,
LEXARIA BIOSCIENCE CORP.
By:
/s/ Richard Christopher
Name:
Richard Christopher
Title:
Chief Executive Officer